Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial
Semaglutide improved physical QoL in patients with schizophrenia, and weight loss may partially contribute to this effect. Longer-term studies are needed to determine whether mental QoL or symptom effects emerge beyond 30 weeks.
Authors
- P. V. Larsen
- P. Gæde
- A. Ganeshalingam
- N. Uhrenholt
- S. Arnfred
- A.K. Pedersen
- J. Frystyk
- N. Bilenberg
Institutions
- University of Southern Denmark (DK)
- Region Zealand (DK)
- Odense University Hospital (DK)
- Copenhagen University Hospital (DK)
- Slagelse Hospital (DK)
- Region of Southern Denmark (DK)
Publication Details
- Journal
- Schizophrenia Research
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1016/j.schres.2026.02.009
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gentofte Hospital
- Region Sjælland